Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
NCT02471352 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 700
Last updated 2026-03-11
Summary
Background:
\- Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them.
Objectives:
\- To determine the causes of various skin diseases and find ways to treat them.
Eligibility:
* People ages 2 and older who have:
* A skin disease or at risk of developing a skin disease OR
* A family member of persons with a skin disease
* Healthy volunteers ages 2 and older
Design:
* Participants will be screened under a separate protocol.
* Participants may take a survey about how their skin condition affects their quality of life.
* Participants will have a medical history and a physical exam including a detailed skin exam. Pictures will be taken of their skin to document any skin disease.
* Participants will have specimens collected. This may include:
* Several teaspoons of blood taken at each visit
* Stool samples
* Nail and body fluid (like saliva) samples
* Cheek swabs. The inside of the cheek will be scraped for about a minute in each direction to collect cells.
* Collection of skin samples with:
* A swab (like a Q-tip)
* Gently scraping skin to remove the outer layers of cells
* Applying and removing 1-inch pieces of tape
* Participants may have up to 4 skin biopsies in 12 months, with 4 separate biopsies taken each time.
* An area of skin will be numbed with an injection.
* A piece of skin the size of a pencil eraser will be removed using a small instrument.
* A flat scar usually develops at the biopsy site.
Conditions
- Dermatologic Conditions
- Healthy Volunteers
- Normal Volunteers
- Carcinoma, Merkel Cell
Sponsors & Collaborators
-
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
lead NIH
Principal Investigators
-
Heidi H Kong, M.D. · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Eligibility
- Min Age
- 1 Day
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2015-06-19
- Primary Completion
- 2027-01-31
- Completion
- 2027-01-31
Countries
- United States
Study Locations
More Related Trials
-
Personalized Therapy of Patients Suffering From Rare Genodermatoses
NCT05680974 ·Status: UNKNOWN
-
Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders
NCT00895271 ·Status: ENROLLING_BY_INVITATION
-
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
NCT04959188 ·Status: COMPLETED
-
Metabolic Profiling of Immune Responses in Immune-mediated Diseases
NCT04864886 ·Status: RECRUITING
-
Study and Treatment of Inflammatory Muscle Diseases
NCT00001265 ·Status: COMPLETED
-
Study of Skin Tumors in Tuberous Sclerosis
NCT00001975 ·Status: RECRUITING
-
Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases
NCT06599411 ·Status: NOT_YET_RECRUITING
-
Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1
NCT07102394 ·Status: RECRUITING ·Phase: PHASE1
-
Skin Biopsy Specimens as Biomarkers of Systemic Sclerosis and Response to Mycophenolate Mofetil
NCT00853788 ·Status: COMPLETED
-
A Safety and Efficacy Study of FCR001 in Adults With Rapidly Progressive Diffuse Cutaneous Systemic Sclerosis
NCT05098145 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
The Validation of New Photographic Technology for Assessing Skin Lesions
NCT06663241 ·Status: COMPLETED
-
Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure
NCT06976073 ·Status: RECRUITING
-
A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
NCT00936546 ·Status: COMPLETED ·Phase: PHASE2
-
Diffuse Cutaneous Scleroderma (DSSc) SFDI Study
NCT07090226 ·Status: RECRUITING ·Phase: NA
-
Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
NCT00001813 ·Status: COMPLETED
-
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
NCT00278525 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa
NCT04213261 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Phase 3 Study of KHK4827 in Patients With Systemic Sclerosis
NCT03957681 ·Status: COMPLETED ·Phase: PHASE3
-
A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
NCT01881529 ·Status: COMPLETED
-
Pilot Tape Harvesting Study
NCT02125695 ·Status: COMPLETED
-
Digital Toolkit for Skin Diseases in LMICs: Part 2
NCT06292260 ·Status: RECRUITING ·Phase: NA
-
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
NCT00005781 ·Status: COMPLETED
-
Efficacy of Granulocyte Colony Stimulating Factor (GCSF) In Patients With Dystrophic Epidermolysis Bullosa
NCT01538862 ·Status: COMPLETED ·Phase: PHASE2
-
People of Color and Dermatology: A Deeper Look at Patients' Perceptions of Care and the Need for Greater Diversity in Dermatology
NCT04991285 ·Status: COMPLETED
-
Research in Skin Inflammation
NCT00026741 ·Status: COMPLETED